Alnylam Pharmaceuticals Inventory, Current And Noncurrent increased by 4.0% to $116.12M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.2%, from $110.35M to $116.12M. Over 5 years (FY 2020 to FY 2025), Inventory, Current And Noncurrent shows an upward trend with a 3.9% CAGR.
other_inventory_current_and_noncurrent| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $96.11M | $110.95M | $122.70M | $122.06M | $132.52M | $141.65M | $161.70M | $163.39M | $162.62M | $136.47M | $125.43M | $126.29M | $120.41M | $115.36M | $115.38M | $110.35M | $100.40M | $96.61M | $111.64M | $116.12M |
| QoQ Change | — | +15.4% | +10.6% | -0.5% | +8.6% | +6.9% | +14.2% | +1.0% | -0.5% | -16.1% | -8.1% | +0.7% | -4.7% | -4.2% | +0.0% | -4.4% | -9.0% | -3.8% | +15.6% | +4.0% |
| YoY Change | — | — | — | — | +37.9% | +27.7% | +31.8% | +33.9% | +22.7% | -3.7% | -22.4% | -22.7% | -26.0% | -15.5% | -8.0% | -12.6% | -16.6% | -16.3% | -3.2% | +5.2% |